Commentary: statins and fracture--why the confusion?
Edwards, C.J. and Arden, N.K. (2006) Commentary: statins and fracture--why the confusion? International Journal of Epidemiology, 35, (5), 1312-1313. (doi:10.1093/ije/dyl137).
Download
Full text not available from this repository.
Original Publication URL: http://dx.doi.org/10.1093/ije/dyl137
Description/Abstract
In 1999 a paper published in Science suggested that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) increased bone formation in rodents by effects on a potent bone forming cytokine bone morphogenetic protein-2 (BMP-2).1 Subsequent studies have suggested that statins increase bone mineral density (BMD) in humans2 and have investigated whether statin use is associated with reduced fracture risk.
| Item Type: | Article |
|---|---|
| ISSNs: | 0300-5771 (print) |
| Related URLs: | |
| Keywords: | editorial, nosp,bone |
| Subjects: | R Medicine R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
| Divisions: | University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair |
| Item ID: | 61070 |
| Date Deposited: | 08 Sep 2008 |
| Last Modified: | 01 Jun 2011 05:00 |
| Contributors: | Edwards, C.J. (Author) Arden, N.K. (Author) |
| Date: | 2006 |
| Status: | Published |
| URI: | http://eprints.soton.ac.uk/id/eprint/61070 |
Actions (login required)
 |
View Item |
